Mukka Proteins

INR
20.48
-0.57 (-2.71%)
BSENSE

Mar 23

BSE+NSE Vol: 4.08 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039185,
    "name": "Mukka Proteins",
    "stock_name": "Mukka Proteins",
    "full_name": "Mukka Proteins Ltd",
    "name_url": "stocks-analysis/mukka-proteins",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.48",
    "chg": -0.57,
    "chgp": "-2.71%",
    "dir": -1,
    "prev_price": "21.05",
    "mcapval": "614.40 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544135,
    "symbol": "MUKKA",
    "ind_name": "FMCG",
    "ind_code": 81,
    "indexname": "India SENSEX",
    "isin": "INE0CG401037",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "4.08 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mukka-proteins-10039185-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mukka Proteins Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mukka-proteins-ltd-is-rated-sell-3905823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MukkaProteinsLt_mojoScore_3905823.png",
        "date": "2026-03-23 10:10:30",
        "description": "Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mukka Proteins Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mukka-proteins-ltd-is-rated-sell-3886613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MukkaProteinsLt_mojoScore_3886613.png",
        "date": "2026-03-12 10:10:52",
        "description": "Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Mukka Proteins Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mukka-proteins-ltd-is-rated-sell-by-marketsmojo-3862985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MukkaProteinsLt_mojoScore_3862985.png",
        "date": "2026-03-01 10:10:24",
        "description": "Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mukka Proteins Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mukka-proteins-ltd-is-rated-sell-3845493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MukkaProteinsLt_mojoScore_3845493.png",
        "date": "2026-02-18 10:11:16",
        "description": "Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mukka Proteins Ltd Quality Parameters Deteriorate Amidst Challenging FMCG Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mukka-proteins-ltd-quality-parameters-deteriorate-amidst-challenging-fmcg-landscape-3841409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MukkaProteinsLt_qualitydot_3841409.png",
        "date": "2026-02-16 08:01:11",
        "description": "Mukka Proteins Ltd has seen its quality grade downgraded from average to below average, reflecting a deterioration in key business fundamentals. The downgrade comes amid declining sales and earnings growth, elevated leverage ratios, and modest returns on capital, signalling caution for investors in this FMCG micro-cap stock."
      },
      {
        "title": "Are Mukka Proteins Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-mukka-proteins-ltd-latest-results-good-or-bad-3840630",
        "imagepath": "",
        "date": "2026-02-14 20:00:29",
        "description": "Mukka Proteins Ltd's latest financial results for Q3 FY26 present a complex picture characterized by significant revenue growth alongside challenges in profitability. The company reported consolidated net sales of ₹653.50 crores, reflecting a substantial sequential increase of 167.19% from the previous quarter and a year-on-year growth of 115.57%. This remarkable topline expansion is attributed to seasonal demand typical in the seafood processing industry, particularly during the peak quarter of October to December.\n\nHowever, the operational margins tell a different story. The operating margin, excluding other income, decreased to 7.16%, down 680 basis points from the same quarter last year. This compression raises concerns regarding the company's pricing power and cost management strategies in a competitive market. Additionally, the profit after tax margin contracted to 4.29%, although it showed a sequenti..."
      },
      {
        "title": "Mukka Proteins Gains 0.36%: 2 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mukka-proteins-gains-036-2-key-factors-driving-the-weekly-move-3838845",
        "imagepath": "",
        "date": "2026-02-14 09:02:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 9:</strong> Stock opens at Rs.24.87, modest gain despite Sensex rally</p>\n                    <p><strong>Feb 10:</strong> Continued incremental gains on rising volumes</p>\n                    <p><strong>Feb 11:</strong> Profit-taking leads to 1.64% decline amid Sensex gains</p>\n                    <p><strong>Feb 12:</strong> Strong rebound with 3.42% surge on heavy volume</p>\n                    <p><strong>Feb 13:</strong> Quarterly results reveal strong turnaround but stock closes lower by 2.20%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.24.87<..."
      },
      {
        "title": "Mukka Proteins Ltd Reports Strong Quarterly Turnaround Amidst FMCG Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mukka-proteins-ltd-reports-strong-quarterly-turnaround-amidst-fmcg-sector-challenges-3837465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MukkaProteinsLt_fintrenddot_3837465.png",
        "date": "2026-02-13 11:01:39",
        "description": "Mukka Proteins Ltd has demonstrated a significant financial turnaround in the quarter ended December 2025, reversing a negative trend to deliver impressive revenue and profit growth. The company’s latest quarterly results reveal a marked improvement in key financial metrics, signalling renewed operational strength within the FMCG sector."
      },
      {
        "title": "Mukka Proteins Q3 FY26: Stellar Revenue Surge Masks Margin Compression Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/mukka-proteins-q3-fy26-stellar-revenue-surge-masks-margin-compression-concerns-3838000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MukkaProteins_quaterlyResult_3838000.png",
        "date": "2026-02-13 10:28:29",
        "description": "Mukka Proteins Ltd., a micro-cap player in India's FMCG seafood processing sector, delivered a spectacular topline performance in Q3 FY26 with net sales surging 167.19% quarter-on-quarter to ₹653.50 crores, marking the highest quarterly revenue in the company's history. However, the impressive sales momentum came at a cost, with consolidated net profit declining 9.56% year-on-year to ₹23.75 crores despite a sequential jump of 303.91%. Trading at ₹24.99 with a market capitalisation of ₹746.00 crores, the stock has corrected 28.50% over the past year, significantly underperforming the FMCG sector's 86.15% gain during the same period."
      }
    ],
    "total": 335,
    "sid": "10039185",
    "stock_news_url": "https://www.marketsmojo.com/news/mukka-proteins-10039185"
  },
  "announcements": [
    {
      "caption": "Intimation Of Name Change Of Subsidiary Entity.",
      "datetime": "17-Mar-2026",
      "details": "Intimation of name change of subsidiary entity.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "09-Mar-2026",
      "details": "Intimation of Analyst/Investor Call.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Mar-2026",
      "details": "Intimation of Analyst/Investor Meet with ICICI Securities and Kotak MF (One on One).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Mukka Proteins Gains 0.36%: 2 Key Factors Driving the Weekly Move

2026-02-14 09:02:53

Key Events This Week

Feb 9: Stock opens at Rs.24.87, modest gain despite Sensex rally

Feb 10: Continued incremental gains on rising volumes

Feb 11: Profit-taking leads to 1.64% decline amid Sensex gains

Feb 12: Strong rebound with 3.42% surge on heavy volume

Feb 13: Quarterly results reveal strong turnaround but stock closes lower by 2.20%

stock-recommendationAnnouncement

Intimation Of Name Change Of Subsidiary Entity.

17-Mar-2026 | Source : BSE

Intimation of name change of subsidiary entity.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

09-Mar-2026 | Source : BSE

Intimation of Analyst/Investor Call.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Mar-2026 | Source : BSE

Intimation of Analyst/Investor Meet with ICICI Securities and Kotak MF (One on One).

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available